Skip to main content

Table 2 Characteristics of lesions

From: Prevalence of cutaneous leishmaniasis infection and clinico-epidemiological patterns among military personnel in Mullaitivu and Kilinochchi districts of the Northern Province, early war-torn areas in Sri Lanka

Lesion features Response category Percentage of respondents (n = 74) Percentage of respondents (n = 74) P-value
Positive for leishmaniasis Negative for leishmaniasis
Number 1 86.5 (n = 64) 86.0 (n = 43) 87.6 (n = 21) 0.536
2 8.2 (n = 6) 10.0 (n = 5) 4.1 (n = 1)
> 2 5.4 (n = 4) 4.0 (n = 2) 8.3 (n = 2)
Site/s Upper limb 66.2 (n = 49) 67.9 (n = 34) 62.6 (n = 15) 0.049
Lower limb 12.2 (n = 9) 6.1 (n = 3) 25.0 (n = 6)
Face 1.4 (n = 1) 2.0 (n = 1) 0 (n = 0)
Head 2.7 (n = 2) 4.0 (n = 2) 0 (n = 0)
Neck 5.4 (n = 4) 4.0 (n = 2) 8.3 (n = 2)
Chest 1.4 (n = 1) 0 (n = 0) 4.1 (n = 1)
Back 8.1 (n = 6) 12.0 (n = 6) 0 (n = 0)
Abdomen 2.7 (n = 2) 4.0 (n = 2) 0 (n = 0)
Type Papule 28.4 (n = 21) 28.0 (n = 14) 29.1 (n = 7) 0.946
Nodule 33.8 (n = 25) 32.0 (n = 16) 37.6 (n = 9)
Plaque 5.5 (n = 4) 6.0 (n = 3) 4.1 (n = 1)
Ulcerated 32.5 (n = 24) 34.0 (n = 17) 29.2 (n = 7)
Size (mm) < 5 5.5 (n = 4) 2.1 (n = 1) 12.5 (n = 3) 0.192
5–10 54 (n = 40) 59.9 (n = 30) 41.7 (n = 10)
11–30 37.8 (n = 28) 36.0 (n = 18) 41.7 (n = 10)
> 30 2.8 (n = 2) 2.0 (n = 1) 4.1 (n = 1)
Shape Round 64.9 (n = 48) 66.0 (n = 33) 62.6 (n = 15) 0.950
Oval 31.1 (n = 23) 30.0 (n = 15) 33.3 (n = 8)
Irregular/other 4.1 (n = 3) 4.0 (n = 2) 4.1 (n = 1)
Margin is well defined Yes 33.8 (n = 25) 28.0 (n = 14) 45.9 (n = 11) 0.048
No 66.2 (n = 49) 72.0 (n = 36) 54.1 (n = 13)
Edge of the lesion Regular 31.1 (n = 23) 24.0 (n = 12) 45.9 (n = 11) 0.047
Irregular 69 (n = 51) 76.0 (n = 38) 54.1 (n = 13)
Consistency Soft 4.1 (n = 3) 2.0 (n = 1) 8.4 (n = 2) 0.045
Firm 90.6 (n = 67) 92.0 (n = 46) 87.5 (n = 21)
Hard 5.5 (n = 4) 6.0 (n = 3) 4.1 (n = 1)
Scaling Yes 44.6 (n = 33) 40.1 (n = 20) 54.3 (n = 13) 0.251
No 55.4 (n = 41) 59.9 (n = 30) 45.7 (n = 11)
Itching Yes 21.7 (n = 16) 18.1 (n = 9) 29.1 (n = 7) 0.047
No 78.4 (n = 58) 81.9 (n = 41) 70.9 (n = 17)
Pain Yes 6.8 (n = 5) 4.0 (n = 2) 12.6 (n = 3) 0.046
No 93.3 (n = 69) 96.0 (n = 48) 87.4 (n = 21)
Pus secretion Yes 18.9 (n = 14) 16.0 (n = 8) 25.0 (n = 6) 0.049
No 81.1 (n = 60) 84.0 (n = 42) 75.0 (n = 18)
Presence of other discharge Yes 25.7 (n = 19) 26.0 (n = 13) 25.0 (n = 6) 0.927
No 74.3 (n = 55) 74.0 (n = 37) 75.0 (n = 18)
Crusting Yes 21.7 (n = 16) 22.0 (n = 11) 21.0 (n = 5) 0.771
No 78.4 (n = 58) 78.0 (n = 39) 79.0 (n = 19)
Skin changes None 8.1 (n = 6) 4.0 (n = 2) 16.6 (n = 6) 0.241
Induration 37.8 (n = 28) 40.0 (n = 20) 33.3 (n = 8)
Erythema 35.2 (n = 26) 38.0 (n = 19) 29.9 (n = 7)
Hypopigmentation 10.8 (n = 8) 8.0 (n = 4) 16.6 (n = 4)
Hyperpigmentation 2.7 (n = 2) 4.0 (n = 2) 0 (n = 0)
Satellite lesion 2.7 (n = 2) 4.0 (n = 2) 0 (n = 0)
Subcutaneous nodules 2.7 (n = 2) 2.0 (n = 1) 4.1 (n = 1)
Scaling 0 (n = 0) 0 (n = 0) 0 (n = 0)
Vesicles 0 (n = 0) 0 (n = 0) 0 (n = 0)
  1. Notes: Suspected individuals with lesions who were confirmed to have leishmaniasis based on diagnostic tests were considered as “positive for leishmaniasis” (n = 50), while the rest were considered as “negative for leishmaniasis” (n = 24)